EQ

Equillium Inc. Common Stock (EQ)

Stock · NASDAQ · Health Care

$2.39as of 8/28/2026

Active signals

No technical signal is currently active for this symbol.

Support level
$1.98
Industry
Biotechnology: Pharmaceutical Preparations

How Equillium Inc. Common Stock Makes Money

Where the revenue actually goes — FY2024 annual results

market-wall.comTotalRevenue$41.09MOther$28.76M (70%)SG&A$11.94M (29%)Tax$400.0K (1%)EQ

Source: 10-K filed Mar 27, 2025 · via SEC EDGAR / Finnhub

Equillium Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • EQ
    Equillium Inc. Common Stock
    $2.39
    ▼ 2.65%
    Market cap $139.10MP/E
  • MIST
    Milestone Pharmaceuticals Inc. Common Shares
    $1.17
    ▼ 2.10%
    Market cap $139.44MP/E
    $1$3.06
  • KZIA
    Kazia Therapeutics Limited American Depositary Shares
    $13.59
    ▼ 19.59%
    Market cap $141.81MP/E
    $4.86$17.4
  • HURA
    TuHURA Biosciences Inc. Common Stock
    $2.11
    ▼ 1.17%
    Market cap $136.28MP/E
    $0.41$3.43
  • GNLX
    Genelux Corporation Common Stock
    $2.66
    ▼ 7.64%
    Market cap $133.62MP/E
    $2.29$8.54
  • ADCT
    ADC Therapeutics SA Common Shares
    $1.15
    ▲ 2.68%
    Market cap $133.55MP/E
    $0.7796$4.98
  • VTVT
    vTv Therapeutics Inc. Class A Common Stock
    $32.17
    ▼ 1.92%
    Market cap $127.58MP/E 55.59
    $15.79$44

P/E shows — for peers not currently carrying a live signal of their own.

Institutional Ownership

March 31, 2026

Total shares held
40.45M
Total value held
$80.87M
Institutional holders
48
Top holders this quarter
  • Unknown6.49M
  • Unknown5.33M
  • Unknown4.45M
  • Unknown3.73M
  • Unknown3.50M
  • Unknown3.35M
  • Unknown3.10M
  • Unknown1.78M
  • Unknown1.64M
  • Unknown1.50M

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.